{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:17:06Z","timestamp":1793895426775,"version":"4.8.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s12098-024-05074-5","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T09:12:37Z","timestamp":1711962757000},"page":"277-283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Supplementation of High-Strength Oral Probiotics Improves Immune Regulation and Preserves Beta Cells among Children with New-Onset Type 1 Diabetes Mellitus: A Randomised, Double-Blind Placebo Control Trial"],"prefix":"10.1007","volume":"92","author":[{"given":"M. N.","family":"Lokesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0039-2142","authenticated-orcid":false,"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neenu","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaivinder","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devi","family":"Dayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,1]]},"reference":[{"key":"5074_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1900\/RDS.2012.9.251","volume":"9","author":"O Vaarala","year":"2012","unstructured":"Vaarala O. Gut microbiota and type 1 diabetes. Rev Diabet Stud. 2012;9:251\u20139.","journal-title":"Rev Diabet Stud"},{"key":"5074_CR2","doi-asserted-by":"publisher","first-page":"7946431","DOI":"10.1155\/2018\/7946431","volume":"2018","author":"D Pagliari","year":"2018","unstructured":"Pagliari D, Saviano A, Newton EE, et al. Gut microbiota-immune system crosstalk andpancreatic disorders. Mediators Inflamm. 2018;2018:7946431.","journal-title":"Mediators Inflamm"},{"key":"5074_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1189\/jlb.3MR1115-500R","volume":"100","author":"C Hotta-Iwamura","year":"2016","unstructured":"Hotta-Iwamura C, Tarbell KV. Type 1 diabetes genetic susceptibility and dendritic cell function: potential targets for treatment. J Leukoc Biol. 2016;100:65\u201380.","journal-title":"J Leukoc Biol"},{"key":"5074_CR4","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3389\/fimmu.2019.00426","volume":"10","author":"P Pandiyan","year":"2019","unstructured":"Pandiyan P, Bhaskaran N, Zou M, Schneider E, Jayaraman S, Huehn J. Microbiome-dependent regulation of Tregs and Th17 cells in mucosa. Front Immunol. 2019;10:426.","journal-title":"Front Immunol"},{"key":"5074_CR5","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2174\/156652412803833634","volume":"12","author":"SM Cabrera","year":"2012","unstructured":"Cabrera SM, Rigby MR, Mirmira RG. Targeting regulatory T cells in the treatment of type 1 diabetes mellitus. Curr Mol Med. 2012;12:1261\u201372.","journal-title":"Curr Mol Med"},{"key":"5074_CR6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1467-789X.2010.00845.x","volume":"12","author":"S de Kort","year":"2011","unstructured":"de Kort S, Keszthelyi D, Masclee AAM. Leaky gut and diabetes mellitus: what is the link? Obes Rev. 2011;12:449\u201358.","journal-title":"Obes Rev"},{"key":"5074_CR7","doi-asserted-by":"publisher","first-page":"7569431","DOI":"10.1155\/2016\/7569431","volume":"2016","author":"J Dolpady","year":"2016","unstructured":"Dolpady J, Sorini C, Di Pietro C, et al. Oral probiotic VSL# 3 prevents autoimmune diabetes by modulating microbiota and promoting indoleamine 2, 3-dioxygenase-enriched tolerogenic intestinal environment. J Diabetes Res. 2016;2016:7569431.","journal-title":"J Diabetes Res"},{"key":"5074_CR8","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3892\/etm.2016.3169","volume":"11","author":"C Li","year":"2016","unstructured":"Li C, Zhang L, Chen Y, Lin X, Li T. Protective role of adenovirus vector-mediated interleukin-10 gene therapy on endogenous islet \u03b2-cells in recent-onset type 1 diabetes in NOD mice. Exp Ther Med. 2016;11:1625\u201332.","journal-title":"Exp Ther Med"},{"key":"5074_CR9","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.2337\/db13-1236","volume":"63","author":"S Robert","year":"2014","unstructured":"Robert S, Gysemans C, Takiishi T, et al. Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. Diabetes. 2014;63:2876\u201387.","journal-title":"Diabetes"},{"key":"5074_CR10","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s00125-005-1831-2","volume":"48","author":"F Calcinaro","year":"2005","unstructured":"Calcinaro F, Dionisi S, Marinaro M, et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia. 2005;48:1565\u201375.","journal-title":"Diabetologia"},{"key":"5074_CR11","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1002\/dmrr.3655","volume":"2023","author":"AR Moravejolahkami","year":"2023","unstructured":"Moravejolahkami AR, Shakibaei M, Fairley AM, Sharma M. Probiotics, prebiotics, and synbiotics in type 1 diabetes mellitus: a systematic review and meta-analysis of clinical trials. Diabetes Metab Res Rev. 2023;e3655. https:\/\/doi.org\/10.1002\/dmrr.3655.","journal-title":"Diabetes Metab Res Rev"},{"key":"5074_CR12","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/pedi.13244","volume":"22","author":"S Kumar","year":"2021","unstructured":"Kumar S, Kumar R, Rohilla L, Jacob N, Yadav J, Sachdeva N. A high potency multi-strain probiotic improves glycemic control in children with new-onset type 1 diabetes mellitus: a randomized, double-blind, and placebo-controlled pilot study. Pediatr Diabetes. 2021;22:1014\u201322.","journal-title":"Pediatr Diabetes"},{"key":"5074_CR13","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1210\/jc.2019-00481","volume":"104","author":"J Ho","year":"2019","unstructured":"Ho J, Nicolucci AC, Virtanen H, et al. Effect of prebiotic on microbiota, intestinal permeability, and glycemic control in children with type 1 diabetes. J Clin Endocrinol Metab. 2019;104:4427\u201340.","journal-title":"J Clin Endocrinol Metab"},{"key":"5074_CR14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2147\/DMSO.S238867","volume":"13","author":"AZ Javid","year":"2020","unstructured":"Javid AZ, Aminzadeh M, Haghighi-Zadeh MH, Jamalvandi M. The effects of synbiotic supplementation on glycemic status, lipid profile, and biomarkers of oxidative stress in type 1 diabetic patients. A placebo-controlled, double-blind, randomized clinical trial. Diabetes Metab Syndr Obes. 2020;13:607\u201317.","journal-title":"Diabetes Metab Syndr Obes."},{"key":"5074_CR15","doi-asserted-by":"publisher","first-page":"e001523","DOI":"10.1136\/bmjdrc-2020-001523","volume":"9","author":"L Groele","year":"2021","unstructured":"Groele L, Szajewska H, Szalecki M, et al. Lack of effect of Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb12 on beta-cell function in children with newly diagnosed type 1 diabetes: a randomised controlled trial. BMJ Open Diabetes Res Care. 2021;9:e001523.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"5074_CR16","doi-asserted-by":"publisher","first-page":"754401","DOI":"10.3389\/fendo.2022.754401","volume":"13","author":"C-H Wang","year":"2022","unstructured":"Wang C-H, Yen H-R, Lu W-L, et al. Adjuvant probiotics of Lactobacillus salivarius subsp. salicinius AP-32, L. johnsonii MH-68, and Bifidobacterium animalis subsp. lactis CP-9 attenuate glycemic levels and inflammatory cytokines in patients with type 1 diabetes mellitus. Front Endocrinol. 2022;13:754401.","journal-title":"Front Endocrinol"},{"key":"5074_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/21645515.2019.1633877","volume":"16","author":"S Bianchini","year":"2020","unstructured":"Bianchini S, Orabona C, Camilloni B, et al. Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine. Hum Vaccin Immunother. 2020;16:86\u201394.","journal-title":"Hum Vaccin Immunother"}],"container-title":["Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-024-05074-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-024-05074-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-024-05074-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:53:58Z","timestamp":1740120838000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-024-05074-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["5074"],"URL":"https:\/\/doi.org\/10.1007\/s12098-024-05074-5","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,1]]},"assertion":[{"value":"30 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}